Clinical trial
Induction and Consolidation Chemotherapy in Locally Advanced Rectal Cancer Patients With Circumferential Resection Margin Involvement: a Multicenter Prospective Randomized Phase III Clinical Trial
NCT04135313 is registered in ClinicalTrials.gov with Blokhin's Russian Cancer Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Induction and Consolidation Chemotherapy in Locally Advanced Rectal Cancer Patients With Circumferential Resection Margin Involvement: a Multicenter Prospective Randomized Phase III Clinical Trial
- Lead sponsor
- Blokhin's Russian Cancer Research Center
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 20, 2019
- Completion date
- October 31, 2024
- Enrollment
- 540 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer, rectal neoplasms malignant, rectum carcinoma